News
BitNile Holdings’ Subsidiary, Digital Power Lending, Makes Strategic Investment in Lab-Grown Diamond Manufacturer
BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or the “Company”) announced today that its subsidiary, Digital Power Lending, LLC (“DP Lending”), has lent
Uni-Bio Science Group Limited: 2022 Interim Results
DGAP-Adhoc: Uniper fully uses existing KfW credit facility and applies for extension of KfW credit facility
Aroundtown SA: Release of a capital market information
DGAP-News: Deutsche Postbank Funding Trust III announces the Netherlands as its home member state
DGAP-Adhoc: Greiffenberger AG: Changes in the Management Board
Sistema PJSFC: Sistema announces financial results for the second quarter 2022
Affluent Medical : Affluent Medical announces the launch of a capital increase with preferential subscription rights (PSR)
DGAP-News: European Commission approves FYB201/Ranivisio®1 (Ranivisio - Ranibizumab), a biosimilar to Lucentis®2
DGAP-News: BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting
Kinarus Therapeutics initiates KIN001 Phase II KINFAST clinical trial in COVID-19 outpatients
Markus Heusser proposed for election as Chairman of the Board of Directors and successor to Urs Kaufmann
Ranger Energy Services, Inc. to Present at the Barclays CEO Energy-Power Conference
Ranger Energy Services, Inc. (NYSE:RNGR) (the “Company”) today announced that Stuart Bodden, Chief Executive Officer, and Melissa Cougle, Chief Financial Officer, will present to members of the
NuStar Energy L.P.’s 2021 Schedule K-3 Now Available
NuStar Energy, L.P. (NYSE: NS) today announced that its 2021 Schedule K-3, reflecting items of international tax relevance, is available online. Unitholders requiring this information may access
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for a booster dose of an Omicron BA.4/BA.5-adapted
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Savara Announces Resignation of Chief Medical Officer
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that Badrul Chowdhury, M.D., Ph.D., has resigned from his role as Chief
DGAP-Adhoc: Formycon announces EU-Approval of FYB201/Ranivisio®1 a biosimilar to Lucentis®2
Power Integrations to Participate in Deutsche Bank Technology Conference
Power Integrations (Nasdaq: POWI) today announced that Sandeep Nayyar, the company’s chief financial officer, will participate in a fireside chat at the Deutsche Bank Technology Conference on
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
